Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis

Bone Marrow Transplant. 2007 Feb;39(3):189-91. doi: 10.1038/sj.bmt.1705554. Epub 2007 Jan 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Benzamides
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Middle Aged
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Recurrence
  • Transplantation, Homologous

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate